[Google Scholar] 38.Hoang VM, Le TV, Chu TTQ, Le BN, Duong MD, Thanh NM, et al
[1] [4] The safety of glutathione injection in patients with severe hepatic or renal impairment has not been established, and its use in these populations should be carefully considered and monitored by a healthcare provider
For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents: To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions
For example, dogs with liver disease have shown altered liver glutathione concentrations, and a supplement containing S-acetyl-glutathione with silybin has been investigated for liver-related outcomes